ConductScience.org, home

Paper27246772

Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.

Mundt HM and 6 others. J Clin Hypertens (Greenwich), 2016. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis. Papers, record 27246772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27246772

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.
PubMed
Journal
J Clin Hypertens (Greenwich)
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2024-08-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mundt HMHeiko M
2Matenaer MMatthias
3Lammert AAlexander
4Göttmann UUwe
5Krämer BKBernhard K
6Birck RRainer
7Benck UUrs

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
HypertensionMajor topic
MinoxidilMajor topic
Renal Insufficiency, ChronicMajor topic
Aged
Drug Therapy, Combination
Female
Humans
Inpatients
Male
Middle Aged
Retrospective Studies
Treatment Outcome

Source PubMed

Download CSV of topics

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17089494Clinical experience of long-term treatment with minoxidil in severe arterial hypertension.Scand J Urol Nephrol1982https://conductscience.org/library/papers/7089494PubMed
22856769Felodipine can replace minoxidil in the treatment of refractory hypertension.J Hypertens Suppl1985https://conductscience.org/library/papers/2856769PubMed
323771844
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Eur Heart J2013https://conductscience.org/library/papers/23771844PubMed
415133413Minoxidil: an underused vasodilator for resistant or severe hypertension.J Clin Hypertens (Greenwich)2004https://conductscience.org/library/papers/15133413PubMed
511677373High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.J Hypertens2001https://conductscience.org/library/papers/11677373PubMed
616891288Resistant hypertension: diagnosis and management.J Cardiovasc Pharmacol Ther2006https://conductscience.org/library/papers/16891288PubMed
795728Minoxidil in resistant hypertension.Lancet1977https://conductscience.org/library/papers/95728PubMed
821896152Direct-acting vasodilators.J Clin Hypertens (Greenwich)2011https://conductscience.org/library/papers/21896152PubMed
921272200Drug therapy for resistant hypertension: simplifying the approach.J Clin Hypertens (Greenwich)2011https://conductscience.org/library/papers/21272200PubMed
1024231917Management of patients with resistant hypertension: current treatment options.Integr Blood Press Control2013https://conductscience.org/library/papers/24231917PubMed
116156351Long-term effects of minoxidil therapy on renal function of patients with refractory hypertension: the significance of albuminuria.J Cardiovasc Pharmacol1980https://conductscience.org/library/papers/6156351PubMed
1221502568Prevalence of resistant hypertension in the United States, 2003-2008.Hypertension2011https://conductscience.org/library/papers/21502568PubMed
1326765793Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety.Blood Purif2016https://conductscience.org/library/papers/26765793PubMed
14603847Long-term treatment of severe hypertension with minoxidil.Can Med Assoc J1977https://conductscience.org/library/papers/603847PubMed
156753777Rapid control of severe hypertension with minoxidil.Arch Intern Med1982https://conductscience.org/library/papers/6753777PubMed
161827043Cardiac changes from beta-blocker, diuretic and minoxidil combination in hypertension.Cardiology1991https://conductscience.org/library/papers/1827043PubMed
17346Treatment of severe hypertension with minoxidil.Isr J Med Sci1975https://conductscience.org/library/papers/346PubMed
184391708Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.N Engl J Med1970https://conductscience.org/library/papers/4391708PubMed
196111848Minoxidil in combination with a beta-adrenergic blocker and a diuretic as an antihypertensive in patients refractory to available medications.S Afr Med J1981https://conductscience.org/library/papers/6111848PubMed
202906371Nifedipine substituted for minoxidil in the treatment of refractory hypertension.J Hum Hypertens1987https://conductscience.org/library/papers/2906371PubMed

See all 50 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42483492A Comprehensive Review on the Efficacy of Antihypertensives in Patients With End-Stage Renal Disease.Int J Hypertens2026https://conductscience.org/library/papers/42483492PubMed
40097761Potential Risks of Minoxidil in Pheochromocytoma and Paraganglioma: A Commentary on Safety Concerns and Mechanisms.Mol Neurobiol2025https://conductscience.org/library/papers/40097761PubMed
40009791I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology.J Bras Nefrol2025https://conductscience.org/library/papers/40009791PubMed
38623369Topical minoxidil reported hair discoloration: a cross-sectional study.Dermatol Reports2024https://conductscience.org/library/papers/38623369PubMed
32796537Towards the Development of AgoKirs: New Pharmacological Activators to Study Kir2.x Channel and Target Cardiac Disease.Int J Mol Sci2020https://conductscience.org/library/papers/32796537PubMed
31792659[Austrian Consensus on High Blood Pressure 2019].Wien Klin Wochenschr2019https://conductscience.org/library/papers/31792659PubMed
29892833Treatment of Hypertension in Chronic Kidney Disease.Curr Hypertens Rep2018https://conductscience.org/library/papers/29892833PubMed
28597403Resistant Hypertension: Mechanisms and Treatment.Curr Hypertens Rep2017https://conductscience.org/library/papers/28597403PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27246772

GET https://conductscience.org/api/papers/v1/27246772/references?page=2